Faslodex Post Marketing Surveillance
NCT00860561 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42
Last updated 2014-10-10
Summary
This PMS aims to assess the efficacy, the safety and tolerability profile of Faslodex in everyday practice. Secondary objective of this PMS is to identify the frequency of serious adverse events or any unknown adverse events of Faslodex.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2013-10-31
- Completion
- 2013-10-31
Countries
- South Korea
Study Locations
More Related Trials
-
Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer
NCT00259090 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer
NCT00241449 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer
NCT00274469 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of 500mg of Fulvestrant
NCT00585507 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer
NCT00570323 ·Status: COMPLETED ·Phase: PHASE2
-
Second Line Breast Cancer Trial
NCT00635713 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Fulvestrant (FASLODEX™) 250 mg and 500 mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy.
NCT00099437 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Global Study to Compare the Effects of Fulvestrant and Arimidex in a Subset of Patients With Breast Cancer.
NCT01602380 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Faslodex +/- Concomitant Arimidex v Exemestane Following Progression on Non-steroidal Aromatase Inhibitors
NCT00253422 ·Status: COMPLETED ·Phase: PHASE3
-
The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer
NCT00065325 ·Status: COMPLETED ·Phase: PHASE3
-
A Treatment With Fulvestrant and Exemestane in Postmenopausal Patients With Advanced Hormone Receptor-Positive (HR) + Breast Cancer
NCT01171417 ·Status: COMPLETED
-
Assessment of Quality of Life, Bone Density and Safety in Postmenopausal Breast Cancer Patients With Letrozole Therapy
NCT00913016 ·Status: UNKNOWN
-
Fulvestrant (Faslodex) + Anastrozole (Arimidex) vs Anastrozole
NCT00543127 ·Status: TERMINATED ·Phase: PHASE3
-
Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast Cancer
NCT00878930 ·Status: COMPLETED
-
Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
NCT00237211 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Electronic Study for Anastrozole Pharmacovigilance Evaluation
NCT00558168 ·Status: COMPLETED
-
Randomized Trial of Fulvestrant With or Without Dasatinib in Men and Postmenopausal Women Who Have Hormone Receptor-positive Advanced Breast Cancer Previously Treated With an Aromatase Inhibitor
NCT00754325 ·Status: COMPLETED ·Phase: PHASE2
-
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
NCT05439499 ·Status: UNKNOWN ·Phase: PHASE3
-
10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)
NCT00885612 ·Status: COMPLETED
-
Casodex - Nolvadex Combination
NCT00637871 ·Status: COMPLETED ·Phase: PHASE2
-
Compare the Value of Prophylactic Versus Therapeutic Breast Radiotherapy in CASODEX
NCT00590213 ·Status: COMPLETED ·Phase: PHASE4
-
Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer
NCT00206414 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women
NCT01069211 ·Status: UNKNOWN
-
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
NCT01077453 ·Status: COMPLETED ·Phase: PHASE1